1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

MR imaging T2 patterns of 37 primary tumor beds in 37 patients 6 weeks posttreatment, pretreatment and posttreatment details, and clinical outcome at the primary site
Posttreatment T2 Pattern (0–3) Pretreatment Primary Tumor Size of Residual Masses (median in cm; range) Local Failure^{^d} Local Control^{^e}
0: Complete resolution No focal mass^{^a} All tumors of expansile intermediate T2 signal without deep extension (size, 1.7–3.6 cm; stage, T4 = 0) 0 (0.0–0.0) 1 2
1: Scar tissue mass Flat-edged/retracted low T2 signal mass^{^b} All tumors of expansile intermediate T2 signal with deep extension (size, 2.0–5.1 cm; stage, T4 = 4) 1.9 (0.7–2.5) 0 14
2: Indeterminate mass Mass without features defined in pattern 1 or 3 All tumors of expansile intermediate T2 signal with deep extension (size, 1.4–7.3 cm; stage, T4 = 7) 2.0 (1.3–3.2) 6 5
3: Residual cancer mass Focal expansile mass ≥ 1 cm in size of intermediate T2 signal^{^c} All tumors of expansile intermediate T2 signal with deep extension (size, 2.9–7.3 cm; stage, T4 = 8) 2.6 (2.0–5.4) 9 0
↵a No abnormality or only expected symmetric changes.
↵b Without any other T2 abnormalities in the residual mass.
↵c Irrespective of other T2 signal abnormalities in the residual mass.
↵d Total = 16.
↵e Total = 21.